Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
Public ClinicalTrials.gov record NCT06467344. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ACDN-01-001: Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Subretinal ACDN-01 in Participants With ABCA4-related Retinopathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is an open-label, single ascending dose clinical trial in participants who have ABCA4-related retinopathies. This is the first-in-human clinical trial in which ACDN-01 will be evaluated for safety, tolerability, and preliminary efficacy following a single subretinal injection of ACDN-01.
Study identification
- NCT ID
- NCT06467344
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 15 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 10, 2024
- Primary completion
- Jul 31, 2030
- Completion
- Nov 30, 2030
- Last update posted
- Dec 1, 2025
2024 – 2030
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of San Francisco | San Francisco | California | 94158 | Recruiting |
| Vitreo Retinal Associates | Gainesville | Florida | 32607 | Recruiting |
| Bascom Palmer Eye Institute | Miami | Florida | 33136 | Recruiting |
| Wilmer Eye Institute at John Hopkins | Baltimore | Maryland | 21218 | Recruiting |
| Massachusetts Eye and Ear | Boston | Massachusetts | 02114 | Recruiting |
| University of Michigan Kellogg Eye Center | Ann Arbor | Michigan | 48105 | Recruiting |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45245 | Recruiting |
| Casey Eye Institute OHSU | Portland | Oregon | 97239 | Recruiting |
| Retina Foundation of the Southwest | Dallas | Texas | 75382 | Recruiting |
| Retina Consultants of Texas | Houston | Texas | 77401 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06467344, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2025 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06467344 live on ClinicalTrials.gov.